Ultrafast Histone Deacetylase Selectivity Screening Using the Agilent RapidFire High-Throughput Mass Spectrometry System
Applications | 2014 | Agilent TechnologiesInstrumentation
The ability to rapidly screen histone deacetylase isoforms for selectivity is critical in early drug discovery to minimize off-target effects and accelerate lead optimization.
This study developed full biochemical assays for four deacetylase enzymes (SIRT1, SIRT3, HDAC1, HDAC6) and evaluated the use of Agilent RapidFire high-throughput mass spectrometry in multiplexed selectivity screening of reference inhibitors.
Enzyme assays were performed at room temperature using acetylated peptide substrates representative of p53 and histone 4. Reactions were carried out in Tris buffer with NAD+ for sirtuins and quenched with formic acid. Multiplexed samples were pooled post-reaction and analyzed at high speed by solid phase extraction (SPE) coupled to tandem mass spectrometry.
Kinetic parameters (Km) and inhibition constants (IC50) determined in multiplexed mode matched those obtained in individual analyses within two-fold and fell within 95% confidence intervals.
Multiplexed data acquisition reached an effective rate of ~3 seconds per sample, enabling ~10 000 MS measurements per 8-hour shift. Inhibition curves for suramin, nicotinamide, valproic acid, and tubacin demonstrated isoform specificity without loss of data quality.
This SPE-MS approach combines label-free detection with throughput comparable to optical assays, reducing artifacts and accelerating selectivity screening in drug discovery, quality control, and enzyme profiling.
Further advances may include expanded multiplex panels, integration with automated liquid handling, real-time data analysis with machine learning, and application to other enzyme families for comprehensive profiling.
The Agilent RapidFire high-throughput MS platform enables ultrafast, reliable selectivity screening of histone deacetylase isoforms, delivering high-quality kinetic and inhibition data at speeds rivaling optical methods.
Regna NL; Reilly CM. Isoform-Selective HDAC Inhibition in Autoimmune Disease. J. Clin. Cell. Immunol. 2014, 5:207.
Sample Preparation, LC/MS, LC/MS/MS, LC/QQQ
IndustriesClinical Research
ManufacturerAgilent Technologies
Summary
Importance of the Topic
The ability to rapidly screen histone deacetylase isoforms for selectivity is critical in early drug discovery to minimize off-target effects and accelerate lead optimization.
Study Objectives and Overview
This study developed full biochemical assays for four deacetylase enzymes (SIRT1, SIRT3, HDAC1, HDAC6) and evaluated the use of Agilent RapidFire high-throughput mass spectrometry in multiplexed selectivity screening of reference inhibitors.
Methodology and Instrumentation
Enzyme assays were performed at room temperature using acetylated peptide substrates representative of p53 and histone 4. Reactions were carried out in Tris buffer with NAD+ for sirtuins and quenched with formic acid. Multiplexed samples were pooled post-reaction and analyzed at high speed by solid phase extraction (SPE) coupled to tandem mass spectrometry.
Instrumentation Used
- Agilent RapidFire 365 SPE system with C4 cartridge
- Agilent 6490 iFunnel Triple Quadrupole mass spectrometer
- Agilent MassHunter acquisition and analysis software
Key Results and Discussion
Kinetic parameters (Km) and inhibition constants (IC50) determined in multiplexed mode matched those obtained in individual analyses within two-fold and fell within 95% confidence intervals.
Multiplexed data acquisition reached an effective rate of ~3 seconds per sample, enabling ~10 000 MS measurements per 8-hour shift. Inhibition curves for suramin, nicotinamide, valproic acid, and tubacin demonstrated isoform specificity without loss of data quality.
Benefits and Practical Applications
This SPE-MS approach combines label-free detection with throughput comparable to optical assays, reducing artifacts and accelerating selectivity screening in drug discovery, quality control, and enzyme profiling.
Future Trends and Applications
Further advances may include expanded multiplex panels, integration with automated liquid handling, real-time data analysis with machine learning, and application to other enzyme families for comprehensive profiling.
Conclusion
The Agilent RapidFire high-throughput MS platform enables ultrafast, reliable selectivity screening of histone deacetylase isoforms, delivering high-quality kinetic and inhibition data at speeds rivaling optical methods.
Reference
Regna NL; Reilly CM. Isoform-Selective HDAC Inhibition in Autoimmune Disease. J. Clin. Cell. Immunol. 2014, 5:207.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
A study of SIRT1- and SIRT2‑Mediated Deacetylation
2022|Agilent Technologies|Applications
Application Note Drug Discovery A study of SIRT1- and SIRT2‑Mediated Deacetylation Using the Agilent RapidFire high-throughput mass spectrometry system Authors Abstract Peter Rye, Lauren Frick, and William Lamarr Agilent Technologies, Inc. The Agilent RapidFire high-throughput mass spectrometry (MS) system is…
Key words
rapidfire, rapidfiresubstrate, substrateenzyme, enzymepeptide, peptidedeacetylation, deacetylationbluesky, blueskysirtuins, sirtuinsvelocities, velocitiesreactions, reactionslinear, linearcourse, courseutility, utilityassays, assaysbinding, bindingmodification
Fragment-Based Drug Discovery: Comparing Labeled and Label-Free Screening of β-Amyloid Secretase (BACE-1) Using Fluorescence Spectroscopy and Ultrafast SPE/MS/MS
2013|Agilent Technologies|Applications
Fragment-Based Drug Discovery: Comparing Labeled and Label-Free Screening of β-Amyloid Secretase (BACE-1) Using Fluorescence Spectroscopy and Ultrafast SPE/MS/MS Application Note Authors Introduction Lauren E. Frick and William A. LaMarr Agilent Technologies, Inc. Wakefield, MA, USA Fragment-based screening offers advantages over…
Key words
unlabeled, unlabeledlfs, lfssubstrate, substratehits, hitslabeled, labeledums, umslms, lmsrapidfire, rapidfirewere, werepeptide, peptideassays, assaysfluorescently, fluorescentlyhit, hitautofluorescence, autofluorescenceinhibition
High-Throughput Analysis of Epigenetic Targets with Agilent RapidFire/MS Systems: Sirtuin (SIRT) Enzymes
2011|Agilent Technologies|Applications
High-Throughput Analysis of Epigenetic Targets with Agilent RapidFire/MS Systems: Sirtuin (SIRT) Enzymes Application Note Author Introduction Peter Rye, Lauren Frick, and William LaMarr Agilent Technologies, Inc. Wakefield, MA USA Histones and other proteins are subject to a variety of posttranslational…
Key words
rapidfire, rapidfiresirtuins, sirtuinssirt, sirtsirtuin, sirtuinpeptide, peptidesustained, sustaineddirect, directsecondary, secondarystudying, studyingkinetic, kineticmultiple, multiplesubstrate, substratefluorescentlytagged, fluorescentlytaggedproducts, productsdeacetylases
High-Throughput MS Detection of Histone H3 Demethylation by Lysine-Specific Demethylase 1 (LSD1)
2011|Agilent Technologies|Applications
High-Throughput MS Detection of Histone H3 Demethylation by Lysine-Specific Demethylase 1 (LSD1) Application Note Author Introduction Peter Rye, Lauren Frick, and William LaMarr Agilent Technologies, Inc. Wakefield, MA USA The field of epigenetics focuses on the investigation of enzymes that…
Key words
rapidfire, rapidfireprotein, proteinconversion, conversionstudying, studyingepigenetic, epigeneticthroughput, throughputconcurrent, concurrentreaction, reactionanalyze, analyzewellsuited, wellsuitedlamarr, lamarrepigenetics, epigeneticsrelieves, relievesnative, nativeparticularly